Collaboration Between Abeona Therapeutics and Beacon to Propel Eye Gene Therapy Innovations
Thursday, 11 July 2024, 11:33
Collaboration for Innovation
Abeona Therapeutics and Beacon have joined forces to accelerate advancements in eye gene therapy.
Revolutionizing Ocular Disease Treatment
- Objective: Drive research and development in genetic therapies for eye diseases.
- Impactful Partnership: Combining expertise and resources for pioneering solutions.
Through this collaboration, the companies aim to revolutionize the landscape of vision care with cutting-edge technologies and breakthrough treatments.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.